全球產前檢測和新生兒篩檢市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球產前檢測和新生兒篩檢市場預計將從2025年的108.1億美元成長至2034年的284億美元，2026年至2034年的複合年成長率（CAGR）為11.33%。隨著醫療專業人員日益重視遺傳和先天性疾病的早期診斷，該市場正經歷強勁成長。產前檢測和新生兒篩檢能夠實現及時的醫療干預，從而改善治療效果並降低長期醫療成本。人們對母嬰健康的日益關注、發展中地區出生率的上升以及診斷技術的不斷進步，都在推動全球市場的擴張。

非侵入性產前檢測、分子診斷和先進篩檢技術的日益普及顯著提高了診斷準確性和患者安全性。各國政府正在擴大新生兒篩檢項目，以便及早發現遺傳性疾病，醫療機構也持續投資先進的檢測基礎設施。不斷成長的醫療支出和公共衛生支援措施進一步推動了市場成長。

隨著個人化醫療和基因組學的不斷進步，產前檢測和新生兒篩檢市場的未來前景依然十分樂觀。人工智慧（AI）輔助診斷、次世代定序和生物標記發現技術的進步將進一步提升篩檢能力。醫療保健服務的普及、對婦幼保健投入的增加以及人們對預防性診斷意識的提高，都將為全球市場創造巨大的成長機會。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球產前檢測與新生兒篩檢市場：按產品分類

• 市場分析、洞察與預測
• 裝置
• 試劑
• 檢測試劑盒
• 其他

第5章 全球產前檢測與新生兒篩檢市場：依診斷方法分類

• 市場分析、洞察與預測
• 非侵入性
• 侵入性

第6章 全球產前檢測與新生兒篩檢市場：依篩檢方法分類

• 市場分析、洞察與預測
• 早期妊娠
• 妊娠中期

第7章 全球產前檢測與新生兒篩檢市場：依技術分類

• 市場分析、洞察與預測
• 串聯式質譜質譜法
• 電泳
• 酵素法和免疫檢測
• 基於DNA的檢測方法
• 脈搏血氧計技術
• 聽力篩檢技術

第8章 全球產前檢測與新生兒篩檢市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • NateraInc
  • PerkinElmerInc
  • IlluminaInc
  • Laboratory Corporation Of America Holdings（Labcorp）
  • Invitae Corporation
  • Centogene NV
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Incorporated
  • BaebiesInc
  • Ravgen Inc
  • Eurofins Scientific SE
  • QIAGEN
  • VeracyteInc
  • NIPD Genetics
  • BGI Group
  • Bio-Rad LaboratoriesInc
  • Thermo Fisher Scientific Inc

The global prenatal testing & newborn screening market size is expected to reach USD 28.40 Billion in 2034 from USD 10.81 Billion in 2025, growing at a CAGR of 11.33 during 2026-2034.This market is witnessing strong growth as healthcare providers increasingly emphasize early diagnosis of genetic disorders and congenital conditions. Prenatal testing and newborn screening enable timely medical intervention, improving treatment outcomes and reducing long-term healthcare costs. Rising awareness regarding maternal and infant health, increasing birth rates in developing regions, and continuous advancements in diagnostic technologies are driving market expansion globally.

Growing adoption of non-invasive prenatal testing, molecular diagnostics, and advanced screening techniques has significantly improved diagnostic accuracy and patient safety. Governments are expanding newborn screening programs to identify inherited disorders at an early stage, while healthcare institutions continue investing in advanced laboratory infrastructure. Increasing healthcare expenditure and supportive public health initiatives are further strengthening market growth.

The future outlook for the prenatal testing and newborn screening market remains highly favorable as personalized medicine and genomic technologies continue advancing. Artificial intelligence-assisted diagnostics, next-generation sequencing, and improved biomarker discovery will enhance screening capabilities. Expanding healthcare access, rising investments in maternal healthcare, and increasing awareness of preventive diagnostics will generate significant growth opportunities worldwide.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Instruments
• Reagents
• Assay Kits
• Others

By Diagnosing Technique

• Non Invasive
• Invasive

By Screening Option

• First Trimester
• Second Trimester

By Technology

• Tandem Mass Spectrometry
• Electrophoresis
• Enzymes & Immuno Assays
• DNA Based Assays
• Pulse Oximetry Technology
• Hearing Screen Technology

COMPANIES PROFILED

• Natera, Inc., PerkinElmer, Inc., Illumina, Inc., Laboratory Corporation of America Holdings (Labcorp), Invitae Corporation, Centogene N.V., F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Baebies, Inc., Ravgen Inc., Eurofins Scientific SE, QIAGEN, Veracyte, Inc., NIPD Genetics, BGI Group, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY DIAGNOSING TECHNIQUE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Diagnosing Technique
• 5.2. Non Invasive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Invasive Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY SCREENING OPTION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Screening Option
• 6.2. First Trimester Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Second Trimester Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Technology
• 7.2. Tandem Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Enzymes & Immuno Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. DNA Based Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Pulse Oximetry Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Hearing Screen Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Diagnosing Technique
  • 8.2.3 By Screening Option
  • 8.2.4 By Technology
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Diagnosing Technique
  • 8.3.3 By Screening Option
  • 8.3.4 By Technology
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Diagnosing Technique
  • 8.4.3 By Screening Option
  • 8.4.4 By Technology
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Diagnosing Technique
  • 8.5.3 By Screening Option
  • 8.5.4 By Technology
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Diagnosing Technique
  • 8.6.3 By Screening Option
  • 8.6.4 By Technology
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PRENATAL TESTING & NEWBORN SCREENING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 NateraInc
  • 10.2.2 PerkinElmerInc
  • 10.2.3 IlluminaInc
  • 10.2.4 Laboratory Corporation Of America Holdings (Labcorp)
  • 10.2.5 Invitae Corporation
  • 10.2.6 Centogene N.V
  • 10.2.7 F. Hoffmann-La Roche Ltd
  • 10.2.8 Quest Diagnostics Incorporated
  • 10.2.9 BaebiesInc
  • 10.2.10 Ravgen Inc
  • 10.2.11 Eurofins Scientific SE
  • 10.2.12 QIAGEN
  • 10.2.13 VeracyteInc
  • 10.2.14 NIPD Genetics
  • 10.2.15 BGI Group
  • 10.2.16 Bio-Rad LaboratoriesInc
  • 10.2.17 Thermo Fisher Scientific Inc